Furthermore, the population of CADM1+ CD7neg CD4+ cells (N) in HTLV-1-positive RA participants was higher than that in HTLV-1-negative RA participants (4.3% vs. 2.5%, p = 0.006) (Figure 2B). This evidence concerns the gene CADM1 and rheumatoid arthritis.